Aftermath of Acute and Chronic Administration of Chloroform Leaf Extract of Vernonia amygdalina on Blood Glucose Levels in Normoglycemic and Streptozotocin-induced Hyperglycemic Mice

Authors

Ogbole EA

Department of Pharmacology and Therapeutics, College of Medical Sciences, Bingham University, Jos Campus, Nigeria. (Nigeria)

Ogundeko TO

Department of Pharmacology and Therapeutics, College of Medical Sciences, Bingham University, Jos Campus, Nigeria. (Nigeria)

Hayab EM

Department of Pharmacy, Bingham University Teaching Hospital, Jos, Nigeria. (Nigeria)

Fwang’an BA

Department of Pharmacy, Bingham University Teaching Hospital, Jos, Nigeria. (Nigeria)

Dangiwa DA

Department of Clinical Pharmacy and Pharmacy Practice, Federal University of Applied Sciences, Kachia, Nigeria (Nigeria)

Ogbole YE

Department of Medicine, Jos University Teaching Hospital, Jos, Nigeria. (Nigeria)

Okoye NP

Department of Pharmacology and Therapeutics, College of Medical Sciences, Bingham University, Jos Campus, Nigeria. (Nigeria)

Ebuga GM

Department of Clinical Pharmacy and Pharmacy Practice, Federal University of Applied Sciences, Kachia, Nigeria (Nigeria)

Article Information

DOI: 10.51244/IJRSI.2026.1304000265

Subject Category: Education

Volume/Issue: 13/4 | Page No: 3123-3130

Publication Timeline

Submitted: 2025-11-14

Accepted: 2025-11-19

Published: 2026-05-18

Abstract

This study evaluated the acute and chronic effects of chloroform extract of Vernonia amygdalina (CHEVA) on blood glucose concentration (BGC) in normoglycemic and streptozotocin (STZ)-induced hyperglycemic mice. Sixty male albino mice were randomized into groups (n = 5). Acute (900 mg/kg) and chronic (300 mg/kg) intraperitoneal doses of CHEVA were administered, while tolbutamide served as standard drug. Hyperglycemia was induced using STZ (50 mg/kg IP). Blood glucose levels were measured at defined intervals. Data were analyzed using repeated-measures ANOVA followed by Tukey post hoc test. CHEVA produced no significant change in normoglycemic mice (p > 0.05). However, significant reductions were observed in STZ-induced mice during chronic treatment (p < 0.05). Phytochemical analysis revealed flavonoids, terpenoids, and alkaloids. The findings support the antidiabetic potential of Vernonia amygdalina, possibly via insulin sensitization and glucose uptake enhancement.

Keywords

Vernonia amygdalina, Diabetes mellitus, Blood glucose, STZ, Phytochemicals

Downloads

References

1. Ijeh, I.I., Ejike, C.E. (2011). Current perspectives on the medicinal potentials of Vernonia amygdalina Del. Afr J Biotechnol, 5(7):1051–61. [Google Scholar] [Crossref]

2. Alara, O. R., Abdurahman, N. H., Mudalip, S. K. A., & Olalere, O. A. (2017). Phytochemical and pharmacological properties of Vernonia amygdalina. Journal of Chemical Engineering and Industrial Biotechnology, 2, 80–89. [Google Scholar] [Crossref]

3. Alara, O. R., Abdurahman, N. H., Ukaegbu, C. I., & Kabbash, N. A. (2019). Extraction and characterization of bioactive compounds in Vernonia amygdalina leaf ethanolic extract comparing Soxhlet and microwave-assisted extraction techniques. Journal of Taibah University for Science, 13(1), 414. https://doi.org/10.1080/16583655.2019.1595231 [Google Scholar] [Crossref]

4. Luo, X., Jiang, Y., Fronczek, F.R., Lin, C., Izevbigie, E.B., Lee, K.S (2011). Isolation and structure determination of a sesquiterpene lactone (vernodalinol) from Vernonia amygdalina extracts. Pharm Biol, 49(5):464–70. [Google Scholar] [Crossref]

5. Bagrov, A. Y., Shapiro, J. I., & Fedorova, O. V. (2009). Endogenous cardiotonic steroids: Physiology, pharmacology, and novel therapeutic targets. Pharmacological Reviews, 61(1), 9–38. https://doi.org/10.1124/pr.108.000711 [Google Scholar] [Crossref]

6. Syahputra RA, Harahap U, Harahap Y, Gani AP, Dalimunthe A, Ahmed A, Zainalabidin S. Vernonia amygdalina Ethanol Extract Protects against Doxorubicin-Induced Cardiotoxicity via TGFβ, Cytochrome c, and Apoptosis. Molecules. 2023 May 24;28(11):4305. doi: 10.3390/molecules28114305. PMID: 37298779; PMCID: PMC10254146. [Google Scholar] [Crossref]

7. Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C. (2020). Pathophysiology of type 2 diabetes mellitus. International Journal of Molecular Sciences, 21(17), 6275. https://doi.org/10.3390/ijms21176275 [Google Scholar] [Crossref]

8. Saeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., ... & IDF Diabetes Atlas Committee. (2019). Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas (9th ed.). Diabetes Research and Clinical Practice, 157, 107843. https://doi.org/10.1016/j.diabres.2019.107843 [Google Scholar] [Crossref]

9. World Health Organization. (2021, September). Diabetes fact sheet. https://www.who.int/news-room/fact-sheets/detail/diabetes [Google Scholar] [Crossref]

10. Gieroba, B., Kryska, A., & Sroka-Bartnicka, A. (2025). Type 2 diabetes mellitus – Conventional therapies and future perspectives in innovative treatment. Biochemistry and Biophysics Reports, 42, 102037. https://doi.org/10.1016/j.bbrep.2025.102037 [Google Scholar] [Crossref]

11. Susilawati, E., Levita, J., Susilawati, Y., & Sumiwi, S. A. (2023). Review of the case reports on metformin, sulfonylurea, and thiazolidinedione therapies in type 2 diabetes mellitus patients. Medical Sciences (Basel), 11(3), 50. https://doi.org/10.3390/medsci11030050 [Google Scholar] [Crossref]

12. Husna, Z., Widodo, R. T., Mahmood, S., Salim, N., Awang, K., Ahmad, N., & Othman, R. (2021). A review on the delivery of plant-based antidiabetic agents using nanocarriers: Current status and their role in combatting hyperglycaemia. Polymers, 14(15), 2991. https://doi.org/10.3390/polym14152991 [Google Scholar] [Crossref]

13. Nyakudya, T. T., Tshabalala, T., Dangarembizi, R., Erlwanger, K. H., & Ndhlala, A. R. (2020). The potential therapeutic value of medicinal plants in the management of metabolic disorders. Molecules, 25(11), 2669. [Google Scholar] [Crossref]

14. Asante, D. B., & Wiafe, G. A. (2023). Therapeutic benefit of Vernonia amygdalina in the treatment of diabetes and its associated complications in preclinical studies. Journal of Diabetes Research, 2023, 3159352. https://doi.org/10.1155/2023/3159352 [Google Scholar] [Crossref]

15. Ogundeko, T. O., Dangiwa, D. A., Hayab, E. M., Okoye, N. P., Fwang’an, B. A., Ogbole, E. A., Ebuga, G. M., & Gyang, S. S. (2025). Effect of acute and chronic administration of hot water extracts of Vernonia amygdalina on some metabolic parameters in STZ-induced hyperglycemic rats. Path of Science, 11(4), 3001–3008. https://doi.org/10.22178/pos.116-3 [Google Scholar] [Crossref]

16. World Health Organization. (2011). Quality control methods for herbal materials. WHO Press. https://apps.who.int/iris/handle/10665/44479 [Google Scholar] [Crossref]

17. Duckworth, W. C. (2001). Hyperglycemia and cardiovascular disease. Current Atherosclerosis Reports, 3(5), 383–391. https://doi.org/10.1007/s11883-001-0075-3 [Google Scholar] [Crossref]

18. Kamalakkannan, N., & Prince, P. S. (2006). Antihyperglycemic and antioxidant effect of rutin, a polyphenolic flavonoid, in streptozotocin-induced diabetic Wistar rats. Basic & Clinical Pharmacology & Toxicology, 98(1), 97–103. https://doi.org/10.1111/j.1742-7843.2006.pto_241.x [Google Scholar] [Crossref]

19. Etuk, E. (2010). Animal models for studying diabetes mellitus. Agriculture and Biology Journal of North America, 1(2), 130–134. https://doi.org/10.5251/abjna.2010.1.2.130.134 [Google Scholar] [Crossref]

20. Kimani, C. N., Mbaria, J. M., Suleiman, M., Gakuya, D., & Kiama, S. G. (2015). Anti-hyperglycemic activity of Zanthoxylum chalybeum stem bark extract in diabetic rats. Journal of Phytopharmacology, 4, 183–189. [Google Scholar] [Crossref]

21. Ogundeko, T. O., Ogbole, E. A., Ebuga, G. M., Hayab, E. M., Fwang’an, B. A., Dangiwa, D. A., & Gyang, S. S. (2022). Screening of some herbal medicine preparations for anti-diabetic activity. IOSR Journal of Pharmacy, 12(8), 9–15. https://www.iosrphr.org [Google Scholar] [Crossref]

22. International Diabetes Federation. IDF Diabetes Atlas. 10th ed. Brussels: International Diabetes Federation; 2021. [Google Scholar] [Crossref]

23. American Diabetes Association. Standards of care in diabetes—2024. Diabetes Care. 2024;47(Suppl. 1):S1–S350. [Google Scholar] [Crossref]

24. Oboh G, Ademiluyi AO, Akinyemi AJ, Henle T, Saliu JA, Schwarzenbolz U. Antioxidant properties of Vernonia amygdalina and its protective effects against oxidative stress. J Food Biochem. 2015;39(4):458–470. [Google Scholar] [Crossref]

Metrics

Views & Downloads

Similar Articles